Companies: 10,795·Total market cap: $144.5T
Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc.

CKPTNASDAQHealthcare
$4.26
+$0.00(+0.00%)
Market Cap$367723200
P/E Ratio
52W High$4.5
52W Low$1.8

Checkpoint Therapeutics, Inc.(CKPT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CKPT · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.04M$0.10M$0.19M$0.27M$1.07M
Cost of Revenue$0.00M$43.57M$49.83M$48.45M$16.35M
Gross Profit$0.04M($43.46M)($49.63M)($48.19M)($15.28M)
Gross Margin %(computed)100.00%
Operating Expenses
R&D Expenses$36.15M$43.57M$49.83M$48.45M$16.35M
G&A Expenses$20.06M$8.69M$8.30M$8.54M$7.92M
Total Operating Expenses$56.22M$52.25M$58.52M$56.99M$24.27M
Operating Income($56.17M)($52.15M)($58.33M)($56.72M)($23.20M)
Operating Margin %(computed)
Interest Income$0.01M$0.08M$0.16M$0.05M$0.12M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($56.24M)($51.85M)($62.62M)($56.67M)($23.08M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($56.24M)($51.85M)($62.62M)($56.62M)($23.08M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.42$-2.77$-7.09$-7.45$-4.13
Wtd Avg Shares39.67M18.74M8.84M7.60M5.58M
EBITDA($56.17M)($52.15M)($53.88M)($56.49M)($23.20M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Checkpoint Therapeutics, Inc.

关于Checkpoint Therapeutics, Inc.(CKPT)损益表

Checkpoint Therapeutics, Inc.(CKPT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,CKPT实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.06B)(净利率-137170.73%)。

常见问题

CKPT · 4 问

Checkpoint Therapeutics, Inc.(CKPT)2024财年营收为$0.00B,同比down60.2%。

CKPT revenueCKPT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09